Triazolam
A benzodiazepine medication used for short-term treatment of insomnia
Triazolam | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Triazolam is a benzodiazepine medication primarily used for the short-term treatment of insomnia. It is known for its fast onset of action and short duration of effect. Triazolam is marketed under various brand names, with Halcion being one of the most well-known.
Medical uses
Triazolam is prescribed for the short-term management of insomnia, particularly in patients who have difficulty falling asleep. Due to its rapid onset, it is effective in reducing the time it takes to fall asleep. However, it is generally recommended for short-term use, typically not exceeding 7 to 10 days, due to the risk of dependence and other adverse effects.
Pharmacology
Triazolam works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, which results in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. Its short half-life makes it suitable for use as a sleep aid, as it reduces the likelihood of next-day sedation.
Side effects
Common side effects of triazolam include drowsiness, dizziness, headache, and nausea. More serious side effects can include memory impairment, confusion, and hallucinations. Due to its potential for abuse and dependence, triazolam is classified as a Schedule IV controlled substance in the United States.
Contraindications
Triazolam is contraindicated in patients with a known hypersensitivity to benzodiazepines, as well as in those with myasthenia gravis, severe respiratory insufficiency, or sleep apnea. It should be used with caution in patients with a history of substance abuse or depression.
Interactions
Triazolam can interact with other medications that depress the central nervous system, such as alcohol, opioids, and other benzodiazepines, leading to increased sedation and respiratory depression. It is also metabolized by the cytochrome P450 enzyme system, particularly CYP3A4, and its effects can be altered by inhibitors or inducers of this enzyme.
History
Triazolam was first introduced in the 1970s and quickly became a popular treatment for insomnia due to its efficacy and short duration of action. However, concerns about its safety profile, particularly regarding its potential for abuse and adverse psychiatric effects, have led to more cautious prescribing practices.
Related pages
References
Triazolam
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD